Fibroblast growth factor 8 (FGF8) has been implicated as an oocyte-associated regulator of follicular function and oocyte developmental competence. Our previous study showed that FGF8 supplementation during porcine in vitro maturation (IVM) improves oocyte maturation and subsequent embryonic development, while FGFR4 is predominantly detected in porcine oocytes. This study investigated whether FGF8 promotes porcine oocyte maturation and early embryonic developmental competence through FGFR4-associated signaling. Porcine cumulus–oocyte complexes were matured in vitro with FGF8, BLU9931, a selective irreversible FGFR4 inhibitor, or both. Nuclear maturation, cumulus expansion, parthenogenetic activation embryo development, downstream phosphorylation responses, embryonic genome activation (EGA)-associated gene expression, mitochondrial function, and apoptosis were evaluated. FGF8 increased pFGFR4 and pFRS2 fluorescence intensity, improved nuclear maturation, cumulus expansion, and blastocyst formation, and enhanced phosphorylation of MAPK, AKT, and STAT3. In contrast, BLU9931 suppressed FGFR4 phosphorylation, reduced meiotic maturation and cumulus expansion, and almost completely blocked blastocyst formation. Co-treatment with FGF8 and BLU9931 failed to restore these developmental outcomes. In 4-cell embryos, FGF8 increased EGA-associated gene expression, mitochondrial membrane potential, and ATP-associated fluorescence, whereas FGFR4 inhibition attenuated these effects. Annexin V/PI staining showed no significant increase in embryonic apoptosis or membrane integrity loss after BLU9931 treatment. These findings indicate that FGF8 supports porcine oocyte maturation and early embryonic development largely through FGFR4-associated signaling during IVM. FGFR4 appears to contribute to developmental competence acquisition by regulating downstream phosphorylation responses, EGA-associated molecular programming, and mitochondrial functional readiness.